(Q67245710)

English

The effect of n-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans

scientific article published on 01 September 1982

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

The effect of n-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans (English)

1 reference

10.1007/BF01640878

https://api.crossref.org/works/10.1007/BF01640878

19 September 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Enterobacter agglomerans

object named as

Enterobacter agglomerans

1 reference

based on heuristic

inferred from title

author name string

A. von Graevenitz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293976

19 September 2023

C. Bucher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293976

19 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6293976

19 September 2023

publication date

1 September 1982

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01640878.pdf

Portable Document Format

1 reference

10.1007/BF01640878

https://api.crossref.org/works/10.1007/BF01640878

19 September 2023

http://link.springer.com/article/10.1007/BF01640878/fulltext.html

1 reference

10.1007/BF01640878

https://api.crossref.org/works/10.1007/BF01640878

19 September 2023

http://link.springer.com/content/pdf/10.1007/BF01640878

1 reference

10.1007/BF01640878

https://api.crossref.org/works/10.1007/BF01640878

19 September 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

293-298

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6293976%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Erwinia infections in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro evaluation of LY127935 (6059S) compared with cefotaxime, eight other β-lactams and two aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of ceftazidime (GR 20263) against nosocomially important pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in nitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility of Acinetobacter calcoaceticus, Serratia marcescens, Pseudomonas fluorescens and Pseudomonas maltophilia to three novel cephalosporin-like antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of ceftazidime and newer antibiotics against Gram-negative bacilli

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sources of Pseudomonas and Acinetobacter Species Found in Human Culture Materials

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The susceptibility of nosocomial pathogens to ceftazidime

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in-vitro activity of ceftazidime against clinically important pathogens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative Activity ofN-Formimidoyl Thienamycin with Third Generation Cephalosporins and Ureido Penicillins against Multiple ResistantSerratia marcescens

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/6293976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic-associated colitis during moxalactam therapy

19

1 reference

10.1007/BF01640878

https://api.crossref.org/works/10.1007/BF01640878

19 September 2023

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67245710&oldid=2218239272"